Switch to:

Beam Therapeutics Total Inventories

: $0.00 Mil (As of Mar. 2020)
View and export this data going back to 2020. Start your Free Trial

Beam Therapeutics's total inventories for the quarter that ended in Mar. 2020 was $0.00 Mil. Beam Therapeutics's average total inventories from the quarter that ended in Dec. 2019 to the quarter that ended in Mar. 2020 was $0.00 Mil.

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value. Beam Therapeutics's liquidation value for the quarter that ended in Mar. 2020 was $192.20 Mil.

Inventory can be measured by days sales of inventory (DSI). Beam Therapeutics's days sales of inventory (DSI) for the three months ended in Mar. 2020 was 0.00.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Beam Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2020 was 0.00.


Beam Therapeutics Total Inventories Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
Total Inventories 0.00 0.00 0.00

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Total Inventories Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Beam Therapeutics Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Beam Therapeutics  (NAS:BEAM) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value.

Beam Therapeutics's liquidation value for the quarter that ended in Mar. 2020 is

Liquidation value (Q: Mar. 2020 )
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=253.442-61.244+0.75 * 0+0.5 * 0
=192.20

2. Inventory can be measured by Days Sales of Inventory (DSI).

Beam Therapeutics's Days Sales of Inventory for the three months ended in Mar. 2020 is

Days Sales of Inventory (DSI)
=Total Inventories (Q: Mar. 2020 )/Revenue (Q: Mar. 2020 )*Days in Period
=0/0.006*365 / 4
=0.00

3. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Beam Therapeutics's Days Inventory for the three months ended in Mar. 2020 is calculated as:

Days Inventory=Total Inventories (Q: Mar. 2020 )/Cost of Goods Sold (Q: Mar. 2020 )*Days in Period
=0/0*365 / 4
=

4. Inventory Turnover measures how fast the company turns over its inventory within a year.

Beam Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2020 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2020 ) / Total Inventories (Q: Mar. 2020 )
=0 / 0
=N/A

5. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Beam Therapeutics's Inventory to Revenue for the quarter that ended in Mar. 2020 is calculated as

Inventory-to-Revenue=Total Inventories (Q: Mar. 2020 ) / Revenue (Q: Mar. 2020 )
=0 / 0.006
=0.00

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Beam Therapeutics Total Inventories Related Terms


Beam Therapeutics Total Inventories Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)